Top Buy
| Security | Buy | Sell | Buy (1M) | Sell (1M) | Price | Target price ▼ | Potential |
|---|---|---|---|---|---|---|---|
| Ultragenyx Pharmaceutical Inc. | 17 | 1 | 1 | 0 | €37.40 | €84.74 | 126.588% |
| Hologic Inc. | 17 | 0 | 4 | 0 | €68.50 | €84.52 | 23.388% |
| Bruker Corp. | 8 | 1 | 2 | 0 | €71.20 | €84.02 | 18.011% |
| Cytokinetics Inc. | 31 | 1 | 8 | 0 | €44.60 | €83.13 | 86.393% |
| Centene Corp. | 15 | 0 | 2 | 0 | €68.79 | €82.57 | 20.033% |
| Lantheus Holdings Inc | 2 | 0 | 0 | 0 | €72.12 | €80.00 | 10.926% |
| Intra-Cellular Therapies Inc. | 25 | 0 | 2 | 0 | €60.50 | €79.55 | 31.495% |
| Henry Schein Inc. | 12 | 1 | 1 | 0 | €66.12 | €79.48 | 20.204% |
| Healthequity Inc. | 1 | 0 | 0 | 0 | €73.50 | €79.00 | 7.483% |
| Incyte Corp. | 12 | 2 | 2 | 0 | €52.84 | €78.42 | 48.415% |
| Bio-Techne Corp. | 10 | 0 | 2 | 0 | €77.00 | €75.94 | -1.382% |
| Boston Scientific | 48 | 0 | 3 | 0 | €70.00 | €73.40 | 4.854% |
| Apellis Pharmaceuticals | 3 | 0 | 0 | 0 | €37.43 | €70.00 | 87.016% |
| Lemaitre Vascular Inc | 2 | 0 | 1 | 0 | €73.00 | €69.00 | -5.479% |
| XOMA Corp. | 6 | 0 | 2 | 0 | €22.80 | €68.78 | 201.664% |
| Axonics Modulation Technologies Inc | 8 | 0 | 0 | 0 | €62.00 | €66.36 | 7.032% |
| Intellia Therapeutics Inc | 13 | 1 | 1 | 1 | €22.91 | €60.55 | 164.313% |
| Celldex Therapeutics | 11 | 1 | 2 | 0 | €33.60 | €56.62 | 68.504% |
| Catalent Inc. | 1 | 0 | 0 | 0 | €50.52 | €55.00 | 8.868% |
| Radnet Inc. | 9 | 3 | 2 | 0 | €54.00 | €54.58 | 1.075% |
| Arrowhead Pharmaceuticals Inc. | 14 | 2 | 2 | 0 | €22.94 | €52.03 | 126.787% |
| Staar Surgical Co. | 12 | 1 | 1 | 0 | €39.03 | €49.33 | 26.383% |
| Pacira Pharmaceuticals | 18 | 0 | 3 | 0 | €27.60 | €47.53 | 72.203% |
| Halozyme Therapeutics Inc. | 15 | 0 | 3 | 0 | €40.40 | €47.17 | 16.757% |
| Rhythm Pharmaceuticals | 15 | 0 | 2 | 0 | €34.00 | €45.98 | 35.235% |